-+ 0.00%
-+ 0.00%
-+ 0.00%

Niagen Bioscience Q3 EPS $(0.01) Misses $0.02 Estimate, Sales $27.192M Miss $32.062M Estimate

Benzinga·11/04/2026 21:04:57
Listen to the news
Niagen Bioscience (NASDAQ:NAGE) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.02 by 150 percent. This is a 120 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $27.192 million which missed the analyst consensus estimate of $32.062 million by 15.19 percent. This is a 19.99 percent decrease over sales of $33.986 million the same period last year.